Cykel AI Secures Major Deal with Transpharmation, Expanding into Pharmaceutical Sector

Mustang Energy Plc ( (GB:CYK) ) has provided an announcement.

Cykel AI has entered into a commercial agreement with Transpharmation Ltd., a leader in neuroscience and pharmaceutical research, to deploy its AI recruitment agent, Lucy, across Transpharmation’s UK and North American operations. This deal opens a new revenue stream for Cykel in the pharmaceutical sector and supports Transpharmation’s market leadership by enhancing their talent acquisition processes. The agreement, which includes a premium enterprise subscription, highlights Lucy’s value in the high-growth pharmaceutical market, reinforcing Cykel’s strategy to monetize its technology in regulated industries. This partnership not only boosts Cykel’s revenue but also lays the groundwork for future commercial opportunities as Transpharmation considers further digital integration.

More about Mustang Energy Plc

Cykel AI specializes in creating autonomous digital workers that perform complex business tasks without human supervision. The company offers a range of AI-driven solutions including Lucy for recruitment, Samson for research analysis, and Eve for sales, all built on its proprietary TaskOS infrastructure. Cykel AI’s digital workers are designed to enhance business operations by working alongside human teams, providing scalable transformation and measurable ROI.

Average Trading Volume: 5,108,386

Technical Sentiment Signal: Sell

Current Market Cap: £13.28M

Find detailed analytics on CYK stock on TipRanks’ Stock Analysis page.